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Abstract
Background: Keeping up-to-date with bioscience literature is becoming increasingly
challenging. Several recent methods help meet this challenge by allowing literature
search to be launched based on lists of abstracts that the user judges to be
‘interesting’. Some methods go further by allowing the user to provide a second
input set of ‘uninteresting’ abstracts; these two input sets are then used to search
and rank literature by relevance. In this work we present the service ‘Caipirini’ (http://
caipirini.org) that also allows two input sets, but takes the novel approach of
allowing ranking of literature based on one or more sets of genes.
Results: To evaluate the usefulness of Caipirini, we used two test cases, one related
to the human cell cycle, and a second related to disease defense mechanisms in
Arabidopsis thaliana. In both cases, the new method achieved high precision in
finding literature related to the biological mechanisms underlying the input data
sets.
Conclusions: To our knowledge Caipirini is the first service enabling literature search
directly based on biological relevance to gene sets; thus, Caipirini gives the research
community a new way to unlock hidden knowledge from gene sets derived via
high-throughput experiments.
Background
Keeping up-to-date with bioscience literature is becoming more challenging as the
number of new papers appearing daily - currently over 2,000 - continues to increase.
As a result, there is an increasing need for methods that can efficiently search this lit-
erature [1], and to this end a wide range of tools and services are now available [2,3].
Currently, most tools used for retrieving bioscience literature are based on keyword
searches, although such approaches have limitations: firstly, it can be difficult for a
researcher to find a set of keywords that exactly specify the biological functions she or
he may be interested in; secondly, the ranking of results is usually not based on rele-
vance to the biological functions of interest. Several recent methods have been pro-
posed to address these limitations, e.g., ETBLAST [4] can launch literature searches
based on a single text document such as an abstract; such methods allow searches to
be defined implicitly, e.g., based on a text of interest, rather than having to explicitly
define keywords. Several tools have extended this approach, allowing collections of
abstracts as input, e.g., PubFinder [5] and MScanner [6].
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reproduction in any medium, provided the original work is properly cited.A common problem with all literature search methods is that only a fraction of the
literature retrieved is truly of interest or relevance for the end-user. Recently, a new
tool, MedlineRanker [7], partly addresses this problem by allowing the end-user to
define two input lists of abstracts - typically, one input list (’A’) can be used for ‘inter-
esting’ abstracts, and the second input list (’B’) for abstracts that are ‘not-interesting’.
MedlineRanker then uses these two input sets to rank a third ‘query’ set of abstracts in
order of interest, based on similarity to input sets A and B. A significant advantage of
this approach is that any retrieved literature that is judged to be uninteresting can be
added subsequently to the ‘uninteresting’ input set, and MedlineRanker can be re-run
to iteratively improve the relevance of the results.
The work presented in this paper was motivated by our collaboration with a group of
experimentalists interested in ranking literature corpora based on similarity to sets of
genes known to be associated with specific phenotypes or conditions. For example, we
were interested in ranking literature based on a set of genes known to be associated
with disease resistance in the plant model organism Arabidopsis thaliana. In a second
case, we wanted to find literature related to the S-phase of the human cell cycle, using
as input one set of genes known to be involved in S-phase, and a second set of ‘back-
ground’ genes known to be involved with all other cell cycle phases, but not S-phase.
In searching for a tool that would suit our purposes, we surveyed existing tools for
ranking and classifying biomedical literature. Many of the existing tools are based on
the ‘Support Vector Machine’ (SVM) approach [8]; however most of these are ‘hard-
wired’ to a particular topic, e.g., alternative transcription [9], human genetic associa-
tions [10], or clinical studies [11]. Of the generic SVM tools that can be trained with
any topic of interest (e.g., BibGlimpse [12]), none allow literature ranking based on
gene lists, although one does precisely the opposite, namely rank genes based on litera-
ture [13]. Of the generic non-SVM tools, some can accept lists of genes as input and
produce a ranked list of literature as output (e.g., Kleio [14]). However, for our pur-
poses the existing methods have some key limitations. Firstly, users can only specify
what they want - they cannot in addition specify what they do not want. We were
interested in a method that would allow users to specify a set of literature they find
uninteresting, and would use this information to improve the relevance and ranking of
subsequent literature searches. A second limitation of existing methods is that they
can only find literature that explicitly mentions genes in the input set. We were inter-
ested in a method that can go beyond these limitations, learn patterns in the literature
associated with the input genes, and potentially return literature that may mention
none of the genes in the input lists, but that discusses biological processes and func-
tions associated with the input genes.
To meet these needs, we developed a new service (’Caipirini’) that, similar to Medli-
neRanker, allows two main input sets, but takes the novel approach of allowing one or
both input sets to be a set of gene identifiers, hence allowing literature search to be
launched based on sets of genes. Caiprini also differs from similar services in that com-
parison of abstracts is based on keywords taken from a large dictionary of nouns and
verbs. In addition, ranking in Caipirini is done using a generic SVM strategy, re-trained
for each input provided by the user. Table 1 summarizes key differences between Cai-
pirini and other comparable literature services.
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Overview of User Workflow
On Caipirini’s home page [15] the user is prompted to provide one list of input identi-
fiers (set A). These identifiers can correspond to Entrez genes [16], Ensembl genes
[17], or Medline abstracts [18] - alternatively, the user may provide a PubMed query
directly as input. On the advanced version (under ‘More Options’) the user is able to
additionally specify a second input list (set B). Sets A and B are typically used to define
an ‘interesting’ and an ‘uninteresting’ (or ‘background’) set. When the user provides
only an ‘interesting’ input set (set A), set B will be automatically filled with the same
number of abstracts as in set A, but randomly chosen from PubMed, excluding
abstracts within set A (see text below for details on how abstracts are associated with
the Set A input when the user specifies genes). The third input set (set C) may contain
a PubMed query or a list of PubMed identifiers - the goal of Caipirini is to rank the
abstracts matching set C in order of similarity to set A (highest rank) and set B (lowest
rank). When the user does not provide a set C, Caipirini will rank all abstracts in Med-
line (indexed by AKS2), and return those with Caiprini score over 85% (see below for
details).
The classification and ranking is based on keywords extracted from abstracts asso-
ciated with sets A and B. By default, Caipirini uses the following keyword types: dis-
eases, symptoms, small molecules, genes/proteins, organisms, and other ‘general
biological terms’. The user can choose to deselect some or all of these types, except for
the so called ‘bio-terms’ and ‘bio-actions’ (i.e., the two groups that comprise the ‘gen-
eral biological terms’), which are always used.
The results comprise mainly of two lists of abstracts from set C: those found with
high certainty to be more similar to set A (’Top Set A Results’) and those more similar
to set B (’Top Set B Results’). Nevertheless, the user has access to Caipirini’sr a n k i n g
scores for all abstracts. A generic outline of Caipirini’s workflow is presented in Figures
1, 2 and 3, where the overview is organized in discrete steps around an imaginary
example-scenario.
Input data and initial processing
For the initial processing of input sets in Caipirini we re-used parts of the pipeline we
developed for Martini [19]. However, after initial processing, the similarity with Martini
ends, and Caipirini uses a very different analysis method (SVM) to achieve a very dif-
ferent goal (ranking of literature).
By default Caipirini assumes that sets ‘A’ and ‘B’ are lists of Entrez gene identifiers
[16], in which case Caipirini retrieves, for each gene, all PubMed identifiers [18] that
are referred to in the Entrez entry, including the GeneRIFs and interaction records.
Table 1 Tools for ranking biomedical literature using document sets
Tool Input Dictionary Method
Sets Genes
Kleio [14] 1 Yes ~2 million entities VSM score
PubFinder [5] 1 No ~100,000 words from Medline Likelihood
MScanner [6] 1 No ~25,000 MeSH terms Bayesian
MedlineRanker [7] 1 or 2 No Detects nouns via syntax Bayesian
Caipirini 2 Yes ~4 million entities SVM
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first translates them to Entrez gene identifiers, and then to the corresponding PubMed
identifiers as above; see Figure 1. The mapping between Ensembl gene, Entrez genes,
and Medline abstracts is retrieved offline using SRS [20] and stored in RAM (random
access memory) to enable fast access while processing jobs.
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Figure 1 Outline of the implemented document classification (Part I). The outline of the implemented
methodology is demonstrated via an imaginary example: the values presented are not real; they are used
just to indicate how the process works. The workflow is presented in steps: in this scenario, (0. Input) the
user entered as input mixed identifiers from Ensembl (ENSG), Entrez (ENTRZ), and PubMed (PMID); Sets A
and B consist the training set abstracts, whereas Set C is the set of abstracts to be classified; next to the
standard background, only terms of type ‘Gene/Protein’ are selected. Then, (1. Data Collection) the entered
data are retrieved and cleaned-up; note that in general there are Entrez identifiers that may falsely pass as
PubMed identifiers (e.g., 90990), and that when there are multiple Ensembl-to-Entrez mappings for the
same identifier they are all utilized - both cases not demonstrated in the example. Last, for the current
version, users have suggested that multiple occurrences of entries and overlaps among sets should not be
removed, e.g., for coping with imbalanced datasets. After the user has defined the input (Step 0) and the
respective abstracts have been collected (Step 1), the extracted data are forwarded for further processing
(Step 2, in Figure 2), for SVM training (Step 3, in Figure 3), and classification (Step 4, in Figure 3); finally, the
results are reported to the user (Step 5, in Figure 3).
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Figure 2 Outline of the implemented document classification (Part II). The outline of the
implemented methodology is demonstrated via an imaginary example (continued): after the input has
been entered and the defined data have been collected (see Figure 1), during the next step (2. Processing)
the abstracts indicated by the user are processed to be eventually represented in the format LIBLINEAR
understands. First the terms pre-determined by the user (and the standard ones) are retrieved, as well as
their frequencies in each abstract (the values presented in the figure do not represent a real scenario; they
are used just to indicate how the process works) - the features used in the vectors correspond only to the
selected terms found in the texts of the abstracts from sets A and B - a meta-arrangement uses vectors
from sets A and B both as training set and default test set.
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Page 4 of 14Alternatively, in the input sets ‘A’ and ‘B’, the end-user can specify either a PubMed
query or a list of PubMed identifiers. For the third input set (’C’), the only formats that
can be used are either a PubMed query, or PubMed identifiers. For PubMed queries,
Caipirini uses Entrez Programming Utilities [21] to retrieve matching PubMed identi-
fiers; see Figure 1. When only set ‘A’ is provided, a second list of PubMed identifiers
(equal in size to the number of abstracts extracted from set ‘A’, but different from those)
are randomly selected to populate set B, whereas set ‘C’ is considered to be all PubMed
abstracts in Caipirini indexed with keywords (including abstracts from sets A and B).
The next step is to convert each PubMed identifier into a list of keywords. For this, we
used an instance of AKS2, a literature analysis tool that was the engine behind the biome-
dical search service Novoseek. AKS2 is based on a keyword dictionary of ~3.7 million
entries covering ~1.8 million genes and proteins, ~1.6 million chemicals, ~30,000 diseases,
~7,000 drugs, ~5,000 bio-actions, ~2,000 symptoms, and ~120,000 other biologically-rele-
vant keywords. The size and breadth of the AKS2 dictionary compares favorably with
similar resources such as Biothesaurus and Unified Medical Language System (UMLS),
both of which have only ~2 million entries. However, our decision to use AKS2 was not
based on its dictionary but on the convenience of one of its services in which the most
recent half of all Medline abstracts have been pre-tagged with its dictionary, resulting in
an average of 32 keywords per abstract. In addition, in previous work we found that AKS2
gave good results for the related task of keyword enrichment [19]. In the present work, we
used AKS2 to construct a hash table in RAM in which each of the ~10 million Medline
abstracts are linked to associated AKS2 keywords. By default, Caipirini uses all keyword
types (genes, chemical, diseases, etc.) for subsequent analysis; however the web interface
allows the user to exclude some types; see Figures 1 and 2.
Caipirini has a number of technical limitations: first, not all Entrez gene records have
associated abstracts; second, some PubMed entries contain only titles, i.e., they have no
abstract text; third, since AKS2 only indexed the most recent half of PubMed, older
abstracts are not used. Finally, to reduce server load and processing time, we have lim-
ited each input field of Caipirini to a maximum number of 25,000 entries, either genes
or abstracts. A job with more than this number of entries specified in any input set
will not run, and the user will be asked to reduce the corresponding list’s size.
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Figure 3 Outline of the implemented document classification (Part III). The outline of the
implemented methodology is demonstrated via an imaginary example (continued): following the initial
data input and processing (see Figures 1 and 2), the next step (3. Training) is to find the best parameter C
for training, based on the vectors from inputs sets A and B - once the optimal SVM configuration for the
specific dataset entered by the user has been found (i.e., the value of C for which the highest five-fold
cross validated accuracy can be achieved), it is used to create the final model. After the training, the SVM
model is used to classify and rank set C, as well as the default test set (4. Classification). Last, result files are
produced and abstracts are listed, ranked according to the predicted scores (5. Results).
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Training Set
If the user has specified genes in either set A or B, these genes are first converted to a
list of abstracts. Next, Caipirini creates one feature vector for each abstract: the vector
has a number of dimensions equal to the total number of unique keywords found in
all abstracts of sets A and B, and a length in each dimension equal to the number of
occurrences of that keyword in the abstract. The same process is followed to create
the vectors for set C with the difference that only terms mentioned in abstracts from
the training set are taken into account; see Figure 2.
SVM Training
In the next step, we search for the best penalty factor C that gives the linear SVM
model with the highest accuracy for the entered dataset - the SVM library used is LIB-
LINEAR [22] with the ‘L2-regularized logistic regression (dual)’ solver and with the tol-
erance termination criterion e set to 0.1 by default. The accuracy is assessed by
LIBLINEAR using five-fold cross-validation with the training data; see Figure 3. Fol-
lowing the notation from [23], Caipirini does the C parameter search in two steps.
Firstly, it evaluates the accuracy at eight points, for c =2
x,w h e r ex in [-3, 4] increased
by 1.0 per step. Then, if the training set is small (i.e., smaller than 5,000 vectors), or if
it is of moderate size (i.e., training vectors are less than 10,000) and the best of the
tested points gives a cross-validated accuracy of less than 80%, Caipirini runs a further
grid search in the neighborhood of the best C, see Table 2.
Classification
The best configuration found during SVM training is used with all input data from set
A and B to construct the final linear SVM model. The solver used allows assigning a
‘Caipirini score’ to each abstract, corresponding to the probability that the abstract
belongs to either set A or B. The vectors from set C are passed into the trained model
so as that each abstract is classified to belong to set A if the SVM assigns a probability
of belonging to set A greater than 0.5. Vectors are assigned to set B using the opposite
criteria. Finally, the abstracts from set C are listed together with their assignments, and
ranked according to the Caipirini scores they received; see Figure 3.
Performance
Many other services based on SVM are trained using pre-defined data, hence ‘hard-
wired’ to a particular topic, with only the classification done on-the-fly (e.g., GAPscre-
ener [10]). Caipirini differs greatly in that the SVM is re-trained for each new input
specified by the user. This approach has the advantage that it is likely to be more
Table 2 Training the SVM: grid search for best penalty parameter c
X C = 2^x Further neighborhood search (C tested also for)
-3.0 0.125 0.05, 0.1, 0.15
-2.0 0.25 0.15, 0.2, 0.3, 0.35
-1.0 0.5 0.3, 0.4, 0.6, 0.7
0.0 1.0 0.75, 1.25, 1.5
1.0 2.0 1.5, 2.5, 3.0
2.0 4.0 3.0, 3.5, 4.5, 5.0, 6.0
3.0 8.0 6.0, 7.0, 9.0, 10.0, 11.0
4.0 16.0 11.0, 12.0, 13.0, 14.0, 15.0
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Page 6 of 14accurate; however a significant penalty is paid in the time taken to train. The exact
time will depend on the size of the input sets, as well as the number of Medline
abstracts per gene. As a guide to performance speed, using random sets of 25,000
abstracts in each set A and B takes about two hours to classify all PubMed abstracts
indexed in Caiprini; however, running time can be highly variable, e.g., depending on
unpredictable factors such as how many abstracts link to each gene, the quality of the
input set, the number of keywords retrieved, the training search, and the server load.
The user can assess the reliability of Caipirini’s performance in two ways. First, the
Caipirini report shows a ‘test set accuracy’, indicating Caipirini’s ability to distinguish
or separate the input sets A and B. In addition, Caipirini reports a measure of the
‘Cross Validation Accuracy’, which is an approximate estimation of the accuracy of
classification for set C; however, this estimation is based on inputs A and B, and the
true classification accuracy will likely be lower, depending on what the user provides
for set C. It would be possible to provide more precise estimations of the classification
accuracy and significance using further re-sampling techniques, such as bootstrapping,
jackknifing, or other permutation tests. However, such approaches have been devel-
oped primarily for quantitative analysis of experiment data, whereas Caipirini is more
qualitative, designed to suggest which papers are interesting. Furthermore, such addi-
tional methods can be computationally expensive (e.g., [24]) and we chose not to use
them, since each Caipirini analysis is already quite slow, primarily due to our use of
five-fold cross-validation.
Datasets
Cell-cycle datasets
To test Caipirini we used a dataset in which 158 human gene identifiers were asso-
ciated with S-phase of the cell cycle, and 456 with the other three phases [19,25]. To
estimate precision and accuracy, we constructed three sets of Medline abstracts using
the queries specified in Table 3. The first set (’S-phase’) contains abstracts that have
been pre-assigned via MeSH terms [26] to S-phase specifically, and not to any of the
other cell-cycle phases. This set was used to calculate true positives and false negatives.
The second set (’Not S-phase’) consists of Medline abstracts that have been assigned to
any of the other cell cycle phases, but not to S-phase. This set was used to calculate
false positives and true negatives. The final set (’Unknown phase’) consists of abstracts
Table 3 PubMed queries used to calculate precision and recall
Dataset PubMed Query Abstracts
S-phase “humans"[MeSH Terms] AND ("S Phase"[MeSH Terms] OR “DNA Replication"[MeSH
Terms]) NOT ("G1 Phase"[MeSH Terms] OR “G2 Phase"[MeSH Terms] OR
“Prophase"[MeSH Terms] OR “Prometaphase"[MeSH Terms] OR “Metaphase"[MeSH
Terms] OR “Anaphase"[MeSH Terms] OR “Telophase"[MeSH Terms] OR
“Cytokinesis"[MeSH Terms]) AND ("2000/01/01"[PDAT]: “2008/06/31"[PDAT])
4,240
Not S-
phase
“humans"[MeSH Terms] AND ("G1 Phase"[MeSH Terms] OR “G2 Phase"[MeSH Terms] OR
“Prophase"[MeSH Terms] OR “Prometaphase"[MeSH Terms] OR “Metaphase"[MeSH
Terms] OR “Anaphase"[MeSH Terms] OR “Telophase"[MeSH Terms] OR
“Cytokinesis"[MeSH Terms]) NOT ("S Phase"[MeSH Terms] OR “DNA Replication"[MeSH
Terms]) AND ("2000/01/01"[PDAT]: “2008/06/31"[PDAT])
4,329
Unknown
phase
“Cell cycle” AND “humans"[MeSH Terms] NOT ("G1 Phase"[MeSH Terms] OR “G2
Phase"[MeSH Terms] OR “Prophase"[MeSH Terms] OR “Prometaphase"[MeSH Terms] OR
“Metaphase"[MeSH Terms] OR “Anaphase"[MeSH Terms] OR “Telophase"[MeSH Terms]
OR “Cytokinesis"[MeSH Terms] OR “S Phase"[MeSH Terms] OR “DNA Replication"[MeSH
Terms]) AND ("2008/01/01"[PDAT]: “2008/06/31"[PDAT])
2,989
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Page 7 of 14that were related to the human cell cycle, but have not been classified by MeSH terms
to any specific phase. This set was used to demonstrate the ability of Caipirini to find
abstracts related to S-phase that could not be identified using MeSH terms.
Arabidopsis datasets
We manually created a set of 90 abstracts wej u d g e dt ob er e l a t e dt op a t h o g e nr e s i s -
tance in Arabidopsis. We also created a second set of 90 abstracts that were also
related to Arabidopsis, but did not specifically discuss pathogen resistance mechanisms.
As a test set, we defined a third set of 216 Arabidopsis-related abstracts for which rele-
vance, or not, to pathogen resistance was initially unknown; this was then tested using
Caipirini and subsequently verified by three curators; see Additional file 1.
Results
Cell-Cycle Dataset
We evaluated the performance of Caipirini using a dataset of 158 gene identifiers asso-
ciated with S-phase and 456 gene identifiers associated with the other three phases of
the human cell cycle (G1, G2, and M). These gene sets were then used as input to Cai-
pirini to rank the results of a PubMed query that specifies ~4,000 abstracts known to
be related to S-phase. The same input gene sets were also used to rank the results of
another query specifying ~4,000 abstracts known to be related to the other cell-cycle
phases, but not S-phase. Caipirini obtained a moderate recall (i.e., 43%), but had high
precision (i.e., 84%); see Figure 4. That is, of all the abstracts predicted by Caipirini to
be related to S-phase, 84% were correctly assigned, and Caipirini found 43% of all the
abstracts known to be S-phase related. To account for the fact that some abstracts
belonged both to the training and to the classified set (which can be a significant issue
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Figure 4 Precision and recall values vs. Caipirini score for cell cycle dataset. For each abstract
matching the query in input set C, Caipirini calculates a score, where a value of > 0.5 means the abstract
is more likely similar to set A than set B (see Methods for details). The graph on the left shows the
relationship between precision, recall, and Caipirini score for the benchmark dataset, where set A are genes
related to S-phase of the cell-cycle and set B are cell-cycle genes not related to S-phase. These sets were
used to rank a set of abstracts already known to be related either to S-phase or to all other cell-cycle
phases. With these data Caipirini achieved a moderate recall value (43% at the default Caipirini score of
0.5), indicating that just less than half of all abstracts truly related to set A were retrieved. However Caipirini
achieved a good precision: 84% of abstracts with a score of > 0.5 are true positives, and higher scores give
increasingly better precision. The graph on the right shows the performance of Caipirini via the
relationship between precision, recall, and false positive rate for the same dataset when the threshold is set
at different Caipirini scores. Note that while Caipirini’s threshold increases from left to right in the Precision
vs. Recall representation (left), in the ROC representations (right) the opposite is implied and Caipirini’s
score increases with direction from right to left.
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Page 8 of 14because the classifier gets to ‘see’ documents of known class and this in turn can influ-
ence performance assessment), we also calculated precision and recall after having
removed the overlap (i.e., after excluding from set C abstracts from the training set):
there were only minor differences observed; the recall reduced to 41% and the preci-
sion remained the same, i.e., 84%.
Another notable characteristic feature of the dataset is the 50% precision at 100%
recall (see Figure 4), which implies a perfectly balanced test data set. Indeed, the two
queries result in abstract lists of comparable size (see Table 3). However, such balance
is unrealistic in information retrieval where ‘uninteresting’ is far more prevalent than
‘interesting’ a n dw eu s e dt h es a m ei n p u tg e n es e t st oc l a s s i f yt h er e s u l t so faf i n a l
query that specified a set of ~2,200 abstracts known to be related to the cell-cycle, but
where the exact cell-cycle phase was not annotated with MeSH terms. For this set, we
manually checked the top 20 abstracts judged by Caipirini to be most likely related to
the S-phase. We found that four of these abstracts explicitly mentioned terms related
to the S-phase (e.g., ‘S-phase’, ‘DNA replication’,o r‘DNA repair’). The remaining six-
teen abstracts did not explicitly mention processes associated with the S-phase, but
they mentioned proteins and genes known to be related to the S-phase (e.g., VCP, p21,
p16, Sp1, E2F, MLH1, and BRCA1) - several of them were included in the input set A.
Unlike the other two cell-cycle queries, where the correct assessment of each abstract
could be determined automatically, for the third case we did not assess all abstracts
since this would have required manually checking the thousands of abstracts predicted
to be interesting or uninteresting, which would be quite arduous while producing
results of little significance. Thus, for this dataset we did not calculate true precision
or recall scores. However, this scenario (as used for the third query) is more similar to
how life scientists are likely to use Caipirini, i.e., many will use queries for set C
matching large numbers of abstracts, whi l eo n l yas m a l lf r a c t i o no ft h et o pr a n k e d
abstracts will usually be of interest.
The three cell cycle jobs lasted 43, 45 and 39 minutes, respectively.
Benchmarking
Clearly similar in style, Caipirini and MedlineRanker serve similar purposes but in very
distinct ways. A first noticeable difference is that MedlineRanker does not facilitate
expanding a list of gene identifiers into a list of linked PubMed identifiers. Although
this may be considered trivial by some, Caipirini takes this burden off the user’s
shoulders. Also, a user does not have to search for multiple synonyms of genes, or to
disambiguate. To compare the performance of the two tools, we extracted from Caipir-
ini the abstracts associated to each list of genes from the cell cycle dataset and used
them as input to MedlineRanker (default settings applied) in order to rank the
abstracts retrieved by the first two queries.
Regarding running time, MedlineRanker was a lot faster, performing the task in only
seven seconds. We also compared the accuracy of these two tools using the cell cycle
dataset, and found that both performed fairly similarly (e.g., for recall 41% MedlineR-
anker achieves a slightly lower precision of 81%), although Caipirini seems to be
slightly more robust (Figure 5). Thus, since MedlineRanker is much faster with similar
performance, it is probably preferable in many cases, except where the user wants to
provide gene lists as input.
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Page 9 of 14Arabidopsis Dataset
In addition to gene sets, Caipirini also allows sets of abstracts to be used as input. As
part of an ongoing project related to disease resistance in plants [27], we tested Caipir-
ini using sets of abstracts related to the model organism Arabidopsis thaliana. In this
case, we used 90 abstracts known to be related to pathogen defense mechanisms in
Arabidopsis (set A) and a further 90 abstracts also related to Arabidopsis but that do
not discuss pathogen defense mechanisms (set B). We used Caipirini to classify 216
Arabidopsis abstracts (set C) that were afterwards independently checked by three of
u s( A B S ,A C W N ,a n dN M S C )a n dm a n u a l l ya ssigned as either related to pathogen
defense mechanisms, or not (see Additional file 1). The criteria used included explicit
mention of either disease-resistance proteins [28], of signaling hormones or other che-
micals involved in disease resistance processes [29], or of processes or pathways
involved in the hypersensitive response in plants [30].
Of the 216 abstracts, 122 were assigned to set A and 30 to set B by all curators,
whereas for 64 there was disagreement. This spread of results underscores the impor-
tance of using several independent annotators in assessing the accuracy of a method:
although the criteria for interesting vs. uninteresting abstracts may be relatively clear
(as specified above), the interpretation of these criteria can vary considerably from
annotator to annotator. Unlike the cell-cycle data, where the correct assessment of
each abstract could be determined automatically, for the Arabidopsis data the ‘correct’
classification was considered to be that defined by the majority vote of the three inde-
pendent assignments (i.e., 166 for set A and 50 for set B).
When using both sets A and B as input, Caipirini achieved 87% precision (i.e., found
188 correct assignments). Because set C is decomposed in two classes of very different
sizes (dominated by set A-like abstracts), we also calculated the Matthew’sc o r r e l a t i o n
coefficient and found that Caipirini achieved a good prediction (with correlation equal
to 0.6). Of the 24 false positives obtained, fourteen were already ambiguously categor-
ized by manual examination (i.e., one out of the three annotators disagreed; but not
the same curator every time), and of the four false negatives, two were also ‘ambiguous’
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Figure 5 Comparison of Caipirini with MedlineRanker in ROC space. Using the cell cycle data set as
benchmark Caipirini can be compared to other tools - When compared with MedlineRanker, the two tools
performed somewhat alike, although Caipirini seems to be slightly better for this dataset. ROC space: recall
(sensitivity) versus false positive rate for the same dataset when the threshold is set at different scores.
MCC*100: to describe also with a single measure the quality of the binary (i.e., two-class; A vs. B)
classifications we used Matthew’s correlation coefficient (MCC) - Generally, it is regarded as a balanced
metric that can be used even if the classes are of very different sizes. MCC values range between -1 and
+1 (Coefficients valued +1, 0, and -1 represent a perfect, an average random, and an inverse prediction,
respectively); in the graphs the MCC value for each score has been multiplied by one hundred.
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Page 10 of 14(i.e., one of the three annotators disagreed; the same one in both cases). When the
curators later focused on the unambiguously annotated as false positive abstracts, they
noted that some could be indeed considered as related to resistance, but ‘indirectly’
(Additional file 2).
In addition, we ran ten different jobs using the same set C but with only the 90
‘interesting’ Arabidopsis abstracts for set A, and using the random option for set B.
These ten runs gave poorer performance than above, with almost all set C abstracts
classified as related to set A. This illustrates the benefit of explicitly defining a back-
ground set (set B), as it can give more focused results, in this case returning a set of
abstracts that almost all relate specifically to pathogen defense mechanisms in
Arabidopsis.
Regarding speed, all eleven jobs lasted between 8 and 12 minutes each.
Both the Arabidopsis and cell-cycle datasets used above are available at the Caiprini
web site as examples [31].
Discussion
One of our key goals in creating Caipirini was to address the needs of experimentalists
interested in using gene lists to guide literature exploration, and to find biologically
relevant abstracts even if these do not explicitly mention the input genes. To our
knowledge, only Caipirini and MedlineRanker enable this functionality, and Caipirini is
the only method that allows the input sets to be defined using lists of genes. For exam-
ple, a scientist may want to rank literature based on the difference between a set of
genes associated to a primary cancer versus those associated with the metastatic form
of the same cancer.
Another related goal of Caipirini - not facilitated otherwise by other tools in this way
- was to allow the exploration of distinct and disjoint literature sets, gaining insight
into the similar concepts they may share. For example, it would be possible to use Cai-
pirini with the Arabidopsis dataset to find abstracts that discuss resistance mechanisms
in other plants (see Additional file 2), effectively using knowledge from one organism
to learn more about equivalent functions in similar ones. Caipirini supports such
usages, particularly via the advanced options, which allow different types of keywords
to be enabled or disabled - we believe that the combination of features provided here
is currently not available in any other service.
In principle, methods such as Caipirini that use two input sets in this way should be
capable of high precision, i.e., we would expect Caipirini to be able to find sets of
abstracts with high likelihood to be related to underlying phenomena of interest. This
is indeed what we see for the cell-cycle benchmark presented in Figure 4, with a preci-
sion of 84% at a Caipirini score of 0.5, and with higher Caipirini scores giving progres-
sively better precision and fewer false positives. Thus for the biologist interested in
using gene sets to search literature, our results suggest that many of the abstracts
found by Caipirini are likely to correctly reflect the underlying biological difference
between the two gene sets, and hence to be of interest.
Nevertheless, the performance (i.e., precision and recall) can vary greatly with differ-
ent input datasets, and using Caipirini for a task may find only a moderate fraction of
all relevant literature, as in the case of the cell cycle dataset. On the other hand, as
shown by the Arabidopsis example, even in cases where the input data consists of only
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good results provided that the input is carefully selected to reflect the focused question
that is asked.
Furthermore, using two input sets offers an interesting possibility to iteratively
improve performance, e.g., by adding falsely classified abstracts to the ‘uninteresting’
input set, and re-running the classification. Such an interactive approach is currently
limited slightly by the fact that Caipirini does not yet allow gene and abstract identi-
f i e r st ob ea d d e dt ot h es a m ei n p u ts e t .I nt h en e a rf u t u r ew ep l a nt oe n a b l es u c h
mixed input sets, and hence to further improve the ability to iteratively increase
performance.
Clearly, a key limitation of Caipirini currently is its slow performance, especially for
large input sets containing many well-studied genes (i.e., genes that are linked to many
Medline abstracts). This is the cost paid for allowing users to train SVMs matching
their particular input data every time. In the near future, we plan several changes that
may improve the speed significantly. Other extensions include optional features, such
as the users choosing whether they wish to be notified via e-mail when a task has fin-
ished, or whether they want statistical significance tests to be performed additionally.
Furthermore, while Caiprini is currently best suited for two-set problems, we also plan
to enable users to enter multiple data sets, or to save and re-use previous results in
order to be able later to classify new sets of abstracts (e.g., the literature of each new
month).
Conclusions
To our knowledge Caipirini is the only service that can search literature directly based
on gene sets. Though it can be slow, Caipirini allows some quite complex, new opera-
tions for extracting biological insight from gene sets. Therefore, Caipirini gives the
research community a new way to unlock hidden knowledge from gene sets derived
via high-throughput experiments.
Availability and requirements
The Caipirini service is freely available at http://caipirini.org.
Additional material
Additional file 1: Caipirini results for the Arabidopsis Dataset. The file contains (a) the annotation of the 216
abstracts of Set C (incl. some comments and notes by the curators), (b) Caipirini results from the ten runs when
Set A was compared with random Sets B as background, and (c) Caipirini results for the case when Set A was
tested against the manually created Set B used as reference.
Additional file 2: Additional discussion on the Arabidopsis Dataset. Detailed explanations from the manual
verification of Caipirini’s results for the Arabidopsis data-set; ‘PMID’ stands for PubMed identifier.
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